NCT02396342 - Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 10, 2015

Primary Completion Date

April 15, 2021

Study Completion Date

April 15, 2021

Conditions

Hemophilia B

Interventions

GENETIC

AAV5-hFIX

AAV5hFIX gene therapy

Trial Locations (7)

uniQure Investigative Site, Copenhagen

uniQure Investigative Site, Berlin

uniQure Investigative Site, Frankfurt

uniQure Investigative Site, Amsterdam

uniQure Investigative Site, Groningen

uniQure Investigative Site, Rotterdam

uniQure Investigative Site, Utrecht